Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Hidemitsu Kitamura(Toyo University), Akinobu Taketomi(Hokkaido University), Junya Ohtake(Hokkaido University), Yujiro Toyoshima(Hokkaido University), Hideki Kawamura(Hokkaido University), Norihiko Takahashi(The University of Tokyo), Yosuke Ohno(Hokkaido University), Shigenori Homma(Hokkaido University)
Cited by 295
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244